Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06594887 · ClinicalTrials.gov registry record · NA
Rectal Spacers Use in Prostate Cancer Radiation Therapy
A NA study of Prostate Cancer, sponsored by Princeton ProCure management.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06594887: Recruiting NA study of Prostate Cancer, sponsored by Princeton ProCure management.
NCT06594887 is a NA study of Prostate Cancer that is actively recruiting participants, run by Princeton ProCure management. The registered enrollment target is 50 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06594887, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Princeton ProCure management.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective, 2-arm clinical trial aims to evaluate the use of rectal spacers in patients with localized prostate cancer scheduled for Proton Beam Therapy (PBT). Up to 50 subjects will be enrolled in this study. Study visits will include screening, spacer placement, treatment planning, end-of-treatment assessment, and follow-up visits at 1, 3, and 6 months.
Conditions Studied
Interventions
- DEVICE SpaceOAR Vue
- DEVICE BioProtect Balloon Implant System
Study Locations (1)
New Jersey
- Procure Proton Therapy Center - Somerset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-09-06 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT06594887 shows while recruiting
NCT06594887 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which SpaceOAR Vue is the first listed.
NCT06594887 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06594887 about?
NCT06594887 is a clinical study titled "Rectal Spacers Use in Prostate Cancer Radiation Therapy". This prospective, 2-arm clinical trial aims to evaluate the use of rectal spacers in patients with localized prostate cancer scheduled for Proton Beam Therapy (PBT). Up to 50 subjects will be enrolled in this study. Study visits will include screening, spacer placement, treatment planning, end-of-t...
What is the current status of trial NCT06594887?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-09-06. Estimated completion is 2025-12.
What conditions does trial NCT06594887 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT06594887?
The interventions under investigation include: SpaceOAR Vue (DEVICE), BioProtect Balloon Implant System (DEVICE).
Who is sponsoring clinical trial NCT06594887?
This trial is sponsored by Princeton ProCure management, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06594887 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06594887's enrollment target sits among peer trials
50 469th of 735 higher than 247 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI